REGN
Regeneron Pharmaceuticals, Inc.
NMS
$602.92
+2.26
(+0.38%)
Deep pullback · -2.83σ
Hot zone
Grade C
Quarterly financials
last 7 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $3.61B | $2.94B | $744.8M | $727.2M | $799.4M | 81.4% | 20.7% | 20.2% |
| 2025-12-31 | $3.88B | $3.30B | $898.6M | $844.6M | $880.0M | 84.9% | 23.1% | 21.7% |
| 2025-09-30 | $3.75B | $3.23B | $1.11B | $1.46B | $1.37B | 86.1% | 29.6% | 38.9% |
| 2025-06-30 | $3.68B | $3.15B | $1.08B | $1.39B | $737.6M | 85.6% | 29.4% | 37.9% |
| 2025-03-31 | $3.03B | $2.56B | $591.7M | $808.7M | $773.6M | 84.7% | 19.5% | 26.7% |
| 2024-12-31 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |
| 2024-09-30 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |